---
title: "Coronary thrombectomy system gains US FDA clearance"
date: "2025-12-12T12:28:58.000Z"
publishedDate: "12 décembre 2025"
summary: "Vesalio has announced US Food and Drug Administration (FDA) 510(k) clearance and the upcoming US commercial launch of enVast, a clot retriever specifically cleared for mechanical thrombectomy in the cardiac circulation. Large thrombus burden (LTB) is a common and challenging finding in patients undergoing primary percutaneous coronary intervention (PCI)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/coronary-thrombectomy-system-gains-us-fda-clearance/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-12-12-coronary-thrombectomy-system-gains-us-fda-clearance"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2022/07/cath-lab-generic.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/coronary-thrombectomy-system-gains-us-fda-clearance/"
---

![Coronary thrombectomy system gains US FDA clearance](http://cardiovascularnews.com/wp-content/uploads/sites/14/2022/07/cath-lab-generic.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/coronary-thrombectomy-system-gains-us-fda-clearance/*

## L’essentiel

Vesalio has announced US Food and Drug Administration (FDA) 510(k) clearance and the upcoming US commercial launch of enVast, a clot retriever specifically cleared for mechanical thrombectomy in the cardiac circulation. Large thrombus burden (LTB) is a common and challenging finding in patients undergoing primary percutaneous coronary intervention (PCI).

## Lien source

https://cardiovascularnews.com/coronary-thrombectomy-system-gains-us-fda-clearance/
